Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection

Hepatology. 2017 Aug;66(2):658-660. doi: 10.1002/hep.29125. Epub 2017 Jun 22.

Authors

Jonathan J Hogan¹, Mary Ann Lim¹, Matthew B Palmer², Roy D Bloom¹, Raymond T Chung³, Meghan E Sise⁴

Affiliations

¹ Division of Nephrology, University of Pennsylvania, Philadelphia, PA.
² Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
³ Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
⁴ Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

PMID: 28211090
DOI: 10.1002/hep.29125

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use
Female
Glomerulosclerosis, Focal Segmental / chemically induced*
Hepatitis C / drug therapy
Humans
Male
Middle Aged
Proteinuria / chemically induced*

Substances

Antiviral Agents